Skip to content Skip to sidebar Skip to footer

Govt invests in Aus production of IV fluid to address ongoing shortages

In a bid to circumvent ongoing global supply chain issues of vital intravenous fluids,…

In a bid to circumvent ongoing global supply chain issues of vital intravenous fluids, the Albanese government has announced they will invest $20 million to ramp up local manufacturing.

Baxter Healthcare production facility in Western Sydney, Australia's only onshore manufacture of IV fluids, will match the $20m investment, ensuring the nation's sovereign capability in delivering critical hospital medicines.

Health Minister Mark Butler said the combined funds will expand Baxter Healthcare's capacity, creating jobs and ensuring the production of 80 million units per year from 2027.

“The Albanese Labor Government is building Australia’s future by ensuring that critical medicines and medical supplies are manufactured here in Australia, by Australians,” Minister Butler said.

“This is an extraordinary investment in IV fluid production.

"Our investment will now cover IV demand for Australia and we will no longer be hostage to overseas supply.

“Baxter Healthcare’s facility has been an important part of manufacturing in Western Sydney for 50 years, and this investment will help it expand to produce another 20 million IV fluid bags every year.

“It means more jobs, more bags of IV fluid, and less dependence on overseas production.”

What about the opioid shortage?

A shift to Australian medication manufacturing is a huge step towards a more sustainable healthcare system, there are

While Palliative Care Australia (PCA) has welcomed the news, questions remain around how the Health Department will address the ongoing pain relief medication problem.

“Ongoing shortages of IV fluids have been a huge concern for clinicians since 2023, but over the same time frame, even longer in some case, we have seen heartbreaking shortages of pain relief medications for people of all ages at the end of life,” Palliative Care Australia chief Camilla Rowland said.

“In the same way that government and industry are now investing in local production to solve the IV fluids shortage, we need to do the same for pain relief medications so that people can die with peace and dignity, and so families aren’t left with the trauma of seeing loved ones in pain and distress.”

Tasmania is the world's largest producer of opium poppies.

PCA reminds the Health Minister that Tasmania is the world's largest producer of opium poppies, supplying “almost half of the world’s demand of the alkaloid material.”

“This is a significant competitive advantage for Australia as global supply chains falter and business models are challenged,” Ms Rowland said.

“Our experience during Covid also demonstrates that we have the skills and capacity to manufacture vaccines locally – at that time we were able to have some independence from supply shortages and global transport challenges and look after our own.

“A future made in Australia must include medicines. Using Australian grown poppies to make pain relief medications for Australians just makes sense.”

Leave a comment